Promethean pushes for CBD registration despite missing clinical trial efficacy target by Steve Jones September 24, 2026September 24, 2026 Sydney-based Promethean BioPharma has opened a $3.2 million capital raise as it revealed plans to fast […]
Financial news in brief: Elixinol record quarter; Avecho identifies new trial sites by Steve Jones July 29, 2026July 30, 2026
Wait for CBD analysis was ‘torture’, says Avecho CEO as talks resume over licencing deals by Steve Jones July 9, 2026July 9, 2026
Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery; Neurotech reassures ASX by Steve Jones April 29, 2026June 8, 2026
Sandoz over-the-counter CBD deal ‘remarkable’, Avecho chair tells AGM by Steve Jones May 28, 2025May 28, 2025
Avecho turns to new investors to raise funds for CBD clinical trial by Steve Jones May 9, 2023April 30, 2024
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024
Emyria strikes commercial deal with Aspen for over-the-counter product by Steve Jones April 4, 2023April 30, 2024
Ecofibre becomes second company to confirm disappointing sleep trial results by Steve Jones January 30, 2023March 13, 2023
Sleepless nights ahead for Cann Group as over-the-counter CBD trial fails the placebo challenge by Steve Jones January 19, 2023January 19, 2023
